A synopsis of serum biomarkers in cutaneous melanoma patients

Dermatology Research and Practice

Volumn 2012, Issue , 2012, Pages

  Vereecken, Pierre ^a   Cornelis, Frank ^a   Van Baren, Nicolas ^b   Vandersleyen, Valérie ^a   Baurain, Jean François ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^b LUDWIG INSTITUTE FOR CANCER RESEARCH   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; C REACTIVE PROTEIN; FIBRONECTIN; GALECTIN 3; GELATINASE A; GELATINASE B; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 8; IPILIMUMAB; LACTATE DEHYDROGENASE; LAMININ; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MELANOMA ANTIGEN 1; MELANOMA ANTIGEN 10; MELANOMA ANTIGEN 2; MELANOMA ANTIGEN 3; MELANOMA ANTIGEN 4; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN P53; PROTEIN S100B; TYROSINE 3 MONOOXYGENASE; VASCULOTROPIN;

AMINO TERMINAL SEQUENCE; ANGIOGENESIS; B LYMPHOCYTE; BODY FLUID; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER IMMUNOTHERAPY; CANCER PATIENT; CANCER PROGNOSIS; CARBOXY TERMINAL SEQUENCE; CELL DIFFERENTIATION; CELL MEMBRANE; CELL MIGRATION; CELL PROLIFERATION; CORRELATION ANALYSIS; CUTANEOUS MELANOMA; FOLLOW UP; GENOMICS; HUMAN; IMMUNE RESPONSE; INFLAMMATORY CELL; MALIGNANT TRANSFORMATION; MELANOGENESIS; MELANOMA CELL; METASTASIS; MICROARRAY ANALYSIS; OUTCOME ASSESSMENT; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEOMICS; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SENSITIVITY AND SPECIFICITY; SEROLOGY; T LYMPHOCYTE; TREATMENT RESPONSE;

EID: 84866060696     PISSN: None     EISSN: 16876113     Source Type: Journal    
DOI: 10.1155/2012/260643     Document Type: Review

References (17)

1. Hamberg A. P., Korse C. M., Bonfrer J. M. G., De Gast G. C., Serum S100B is suitable for prediction and monitoring of response to chemoimmunotherapy in metastatic malignant melanoma. Melanoma Research 2003 13 1 45 49 2-s2.0-0037331570 10.1097/00008390-200302000-00008 (Pubitemid 36269813)
2. Hauschild A., Michaelsen J., Brenner W., Rudolph P., Gläser R., Henze E., Christophers E., Prognostic significance of serum S100B detection compared with routine blood parameters in advanced metastatic melanoma patients. Melanoma Research 1999 9 2 155 161 2-s2.0-0032803996 (Pubitemid 29331524)
3. Deichmann M., Benner A., Kuner N., Wacker J., Waldmann V., Näher H., Are responses to therapy of metastasized malignant melanoma reflected by decreasing serum values of S100 β or melanoma inhibitory activity (MIA)? Melanoma Research 2001 11 3 291 296 2-s2.0-0034960032 10.1097/00008390- 200106000-00011 (Pubitemid 32578816)
4. Deichmann M., Benner A., Bock M., Jäckel A., Uhl K., Waldmann V., Näher H., S100-beta, melanoma-inhibiting activity, and lactate dehydrogenase discriminate progressive from nonprogressive American joint committee on cancer stage IV melanoma. Journal of Clinical Oncology 1999 17 6 1891 1896 2-s2.0-0033032641 (Pubitemid 29269262)
5. Deichmann M., Kahle B., Moser K., Wacker J., Wüst K., Diagnosing melanoma patients entering American joint committee on cancer stage IV, C-reactive protein in serum is superior to lactate dehydrogenase. British Journal of Cancer 2004 91 4 699 702 2-s2.0-4344701616 (Pubitemid 39141627)
6. Retsas S., Henry K., Mohammed M. Q., MacRae K., Prognostic factors of cutaneous melanoma and a new staging system proposed by the American Joint Committee on Cancer (AJCC): validation in a cohort of 1284 patients. European Journal of Cancer 2002 38 4 511 516 2-s2.0-0036188550 10.1016/S0959-8049(01) 00394-X (Pubitemid 34185390)
7. Bosserhoff A. K., Küster H., Hein R., Elevated MIA levels in the serum of pregnant women and of children. Clinical and Experimental Dermatology 2004 29 6 628 629 2-s2.0-9644290704 10.1111/j.1365-2230.2004.01623.x (Pubitemid 39573653)
8. Sonesson B., Eide S., Ringborg U., Rorsman H., Rosengren E., Tyrosinase activity in the serum of patients with malignant melanoma. Melanoma Research 1995 5 2 113 116 2-s2.0-0028965571
9. Tsao H., Nadiminti U., Sober A. J., Bigby M., A meta-analysis of reverse transcriptase-polymerase chain reaction for tyrosinase mRNA as a marker for circulating tumor cells in cutaneous melanoma. Archives of Dermatology 2001 137 3 325 330 2-s2.0-0035076048 (Pubitemid 32240787)
10. Curry B. J., Myers K., Hersey P., MART-1 is expressed less frequently on circulating melanoma cells in patients who develop distant compared with locoregional metastases. Journal of Clinical Oncology 1999 17 8 2562 2571 2-s2.0-0032804464 (Pubitemid 29368259)
11. Visser M., Velders M. P., Rudolf M. P., Kast W. M., Nickoloff B. J., Molecular characterization of melanoma-derived antigens. Melanoma: Methods and Protocols 2001 61 1st Totowa, NJ, USA Humana Methods in Molecular Medicine
12. Yurkovetsky Z. R., Kirkwood J. M., Edington H. D., Marrangoni A. M., Velikokhatnaya L., Winans M. T., Gorelik E., Lokshin A. E., Multiplex analysis of serum cytokines in melanoma patients treated with interferon-alpha2b. Clinical Cancer Research 2007 13 8 2422 2428 2-s2.0-34247868145 10.1158/1078-0432.CCR-06-1805 (Pubitemid 46698593)
13. Boyano M. D., Garcia-Vazquez M. D., Lopez-Michelena T., Gardeazabal J., Bilbao J., Canavate M. L., Galdeano A. G. D., Izu R., Diaz-Ramon L., Raton J. A., Diaz-Perez J. L., Soluble interleukin-2 receptor, intercellular adhesion molecule-1 and interleukin-10 serum levels in patients with melanoma. British Journal of Cancer 2000 83 7 847 852 2-s2.0-0033826940
14. Vuoristo M. S., Laine S., Huhtala H., Parvinen L. M., Hahka-Kemppinen M., Korpela M., Kumpulainen E., Kellokumpu-Lehtinen P., Serum adhesion molecules and interleukin-2 receptor as markers of tumour load and prognosis in advanced cutaneous melanoma. European Journal of Cancer 2001 37 13 1629 1634 2-s2.0-0034880648 10.1016/S0959-8049(01)00192-7 (Pubitemid 32778608)
15. Vihinen P. P., Hilli J., Vuoristo M. S., Syrjänen K. J., Kähäri V. M., Pyrhönen S. O., Serum VEGF-C is associated with metastatic site in patients with malignant melanoma. Acta Oncologica 2007 46 5 678 684 2-s2.0-34250376358 10.1080/02841860600965020 (Pubitemid 46911902)
16. Osella-Abate S., Quaglino P., Savoia P., Leporati C., Comessatti A., Bernengo M. G., VEGF-165 serum levels and tyrosinase expression in melanoma patients: correlation with the clinical course. Melanoma Research 2002 12 4 325 334 2-s2.0-0036021004 10.1097/00008390-200208000-00004 (Pubitemid 34816437)
17. Hasegawa M., Takata M., Hatta N., Wakamatsu K., Ito S., Takehara K., Simultaneous measurement of serum 5-S-cysteinyldopa, circulating intercellular adhesion molecule-1 and soluble interleukin-2 receptor levels in Japanese patients with malignant melanoma. Melanoma Research 1997 7 3 243 251 2-s2.0-0030844698 (Pubitemid 27283506)